Biphasic insulin aspart Prescribing at MIDDLEWOOD PARTNERSHIP
Drugs used in diabetes | Endocrine System
Items (12m)
293
Total Quantity
2,274
NHS Cost
£13.6K
vs National Avg
+188.6%
MIDDLEWOOD PARTNERSHIP prescribed 293 items of Biphasic insulin aspart over the last 12 months at a cost of £13,564 to the NHS. This is 188.6% above the national average prescribing rate. Biphasic insulin aspart is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
25
Jul 2026
27
Jul 2026
31
Jul 2026
24
Jul 2026
24
Jul 2026
27
Jul 2026
26
Jul 2026
23
Jul 2026
29
Jul 2026
15
Jul 2026
19
Jul 2026
23
Prescribing Details
| Total Items | 293 |
|---|---|
| Total Quantity | 2,274 |
| Total NHS Cost | £13,564 |
| Presentations | 2 different forms |
| vs National Average | +188.6% |
Biphasic insulin aspart Prescribing Comparison
| This practice | 293 items |
|---|---|
| National average per practice | 102 items |
| Difference | +188.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.